FMP
Jan 30, 2026
Kenvue Inc. (NYSE: KVUE) is a prominent player in the consumer health industry, known for its wide range of health and wellness products. The company operates in a competitive market, with rivals like Procter & Gamble and Johnson & Johnson. On January 29, 2026, Jefferies set a price target of $18 for KVUE, while the stock was trading at $17.20, indicating a potential upside of about 4.65%.
Despite this optimistic target from Jefferies, KVUE has received a consensus "Hold" rating from eighteen brokerages, as reported by Marketbeat. Among these, twelve analysts recommend holding the stock, while five suggest buying, and one strongly recommends buying. The average 1-year target price from these analysts is $20.23, suggesting a more bullish outlook compared to Jefferies' target.
Recent analyst reports show mixed sentiments. Johnson Rice maintained a "neutral" rating, while Citigroup lowered its price target from $20.00 to $17.00, keeping a "neutral" stance. Canaccord Genuity Group also reaffirmed a "hold" rating, significantly reducing its price objective from $26.00 to $15.00. These varied opinions reflect the uncertainty surrounding KVUE's future performance.
Currently, KVUE's stock price on the NYSE is $17.20, a slight decrease of 0.81% or $0.14. The stock has experienced fluctuations today, ranging from a low of $17.18 to a high of $17.44. Over the past year, KVUE has seen a high of $25.17 and a low of $14.02, indicating significant volatility in its stock price.
Kenvue's market capitalization is approximately $32.96 billion, with a trading volume of 42.63 million shares. This substantial market cap and trading volume highlight the company's strong presence in the market, despite the mixed analyst ratings and recent price fluctuations.
Kenvue Inc. (NYSE: KVUE) is a prominent player in the consumer health industry, offering a range of products that cater ...
Palantir Technologies Inc. (NASDAQ: PLTR) is a prominent player in the software industry, known for its data analytics p...